v3.26.1
Share-based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation
The following table presents total share-based compensation expense within each functional line item on the condensed consolidated statements of operations for the three and six months ended June 30, 2026 and 2025 (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
  2026202520262025
Cost of revenues$281 $55 $462 $107 
Research and development242 266 447 534 
Sales and marketing671 143 1,198 289 
General and administrative1,855 1,190 3,246 2,325 
      Total$3,049 $1,654 $5,353 $3,255 
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity for the six months ended June 30, 2026:
Outstanding — December 31, 20251,517,039 
Granted— 
Exercised(38,672)
Canceled(63,725)
Outstanding — June 30, 20261,414,642 
Exercisable — June 30, 2026455,465 
Schedule of Stock Options, Valuation Assumptions The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the awards:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)10
Risk-free interest rate4.57 %
Volatility84.00 %
Expected dividend yield— %
The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the Market-based CEO RSUs:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)3
Risk-free interest rate4.25 %
Volatility105.63 %
Expected dividend yield— %
Correlation coefficient0.3741
Schedule of Restricted Stock Unit Activity
The following table summarizes the Company’s RSU activity for the six months ended June 30, 2026:
Non-vested — December 31, 20251,846,156 
Granted139,381 
Vested(235,900)
Forfeited(108,907)
Non-vested — June 30, 20261,640,730